DRG-Blog

A Cost–Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke

21 Juni, 2011 | DRG International, Fachartikel, Finanzierung

Anthony S. Kim, MD; Mai Nguyen-Huynh, MD, MAS; S. Claiborne Johnston, MD, PhD :
A Cost–Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke
Stroke. 2011, Published online before print June 2, 2011, American Heart Association

[DOI: 10.1161/STROKEAHA.110.606889]

« Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors

Der Frühreha-Barthel-Index – The Early Rehabilitation Barthel Index (ERBI) »

Write a comment

You must be logged in to post a comment.

A Cost–Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke

Write a comment

Schlagwörter

Kategorien

Letzte Artikel

Bookmarklets

Blogroll

Meta